Furthermore, the administration of tumour-derived IL-1β into tumour-bearing mice was shown to significantly suppress tumour growth by inducing an influx of tumour-associated neutrophils (TANs) to the tumour site, while the decrease of TANs significantly abrogated IL-1β-mediated antitumour activity [44]. Here, IL1B is linked to neoplasm.